Back to Results
First PageMeta Content
Organofluorides / Atypical antipsychotics / Pharmacology / Piperidines / Lactams / Paliperidone / European Medicines Agency / Risperidone / Antipsychotic / Chemistry / Organic chemistry / Psychiatry


16 December 2010 EMA[removed]Committee for medicinal products for human use (CHMP)
Add to Reading List

Document Date: 2013-07-21 06:09:20


Open Document

File Size: 50,58 KB

Share Result on Facebook

City

London / /

Company

Janssen-Cilag International NV / /

Country

United Kingdom / /

/

Facility

Canary Wharf / /

IndustryTerm

injection site / active breakdown product / medicinal product / medicinal products / /

MedicalCondition

insomnia / hypertension / schizophrenia / parkinsonism / headache / nausea / dyskinesia / upper abdominal pain / rash / back pain / tremor / vomiting / pain / toothache / tachycardia / restlessness / infection / dystonia / high blood pressure / dizziness / constipation / tiredness / upper respiratory tract infection / akathisia / /

Organization

European Medicines Agency / European Commission / Committee for Medicinal Products for Human Use / European Union / E-mail info@ema.europa.eu Website www.ema.europa.eu An / /

/

Product

risperidone / /

PublishedMedium

the European / /

URL

www.ema.europa.eu / /

SocialTag